204 related articles for article (PubMed ID: 24307763)
21. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
22. Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells.
Schlatter P; Beglinger C; Drewe J; Gutmann H
Regul Pept; 2007 Jun; 141(1-3):120-8. PubMed ID: 17276524
[TBL] [Abstract][Full Text] [Related]
23. Role of 4-hydroxynonenal in epidermal growth factor receptor-mediated signaling in retinal pigment epithelial cells.
Vatsyayan R; Chaudhary P; Sharma A; Sharma R; Rao Lelsani PC; Awasthi S; Awasthi YC
Exp Eye Res; 2011 Feb; 92(2):147-54. PubMed ID: 21134369
[TBL] [Abstract][Full Text] [Related]
24. Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway.
Gupta NA; Mells J; Dunham RM; Grakoui A; Handy J; Saxena NK; Anania FA
Hepatology; 2010 May; 51(5):1584-92. PubMed ID: 20225248
[TBL] [Abstract][Full Text] [Related]
25. GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice.
Jolivalt CG; Fineman M; Deacon CF; Carr RD; Calcutt NA
Diabetes Obes Metab; 2011 Nov; 13(11):990-1000. PubMed ID: 21635674
[TBL] [Abstract][Full Text] [Related]
26. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
Wu X; Li S; Xue P; Li Y
Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
[TBL] [Abstract][Full Text] [Related]
27. Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation.
Barale C; Buracco S; Cavalot F; Frascaroli C; Guerrasio A; Russo I
Thromb Haemost; 2017 Jun; 117(6):1115-1128. PubMed ID: 28405672
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes.
Mima A; Hiraoka-Yamomoto J; Li Q; Kitada M; Li C; Geraldes P; Matsumoto M; Mizutani K; Park K; Cahill C; Nishikawa S; Rask-Madsen C; King GL
Diabetes; 2012 Nov; 61(11):2967-79. PubMed ID: 22826029
[TBL] [Abstract][Full Text] [Related]
29. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.
Yusta B; Somwar R; Wang F; Munroe D; Grinstein S; Klip A; Drucker DJ
J Biol Chem; 1999 Oct; 274(43):30459-67. PubMed ID: 10521425
[TBL] [Abstract][Full Text] [Related]
30. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing.
Xu KP; Yu FS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286
[TBL] [Abstract][Full Text] [Related]
31. The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways.
Koehler JA; Yusta B; Drucker DJ
Mol Endocrinol; 2005 Feb; 19(2):459-73. PubMed ID: 15471943
[TBL] [Abstract][Full Text] [Related]
32. Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.
Roed SN; Nøhr AC; Wismann P; Iversen H; Bräuner-Osborne H; Knudsen SM; Waldhoer M
J Biol Chem; 2015 Jan; 290(2):1233-43. PubMed ID: 25451942
[TBL] [Abstract][Full Text] [Related]
33. GLP-1 inhibits VEGFA-mediated signaling in isolated human endothelial cells and VEGFA-induced dilation of rat mesenteric arteries.
Egholm C; Khammy MM; Dalsgaard T; Mazur A; Tritsaris K; Hansen AJ; Aalkjaer C; Dissing S
Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1214-H1224. PubMed ID: 27638877
[TBL] [Abstract][Full Text] [Related]
34. Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy.
Kolibabka M; Dietrich N; Klein T; Hammes HP
Diabetologia; 2018 Nov; 61(11):2412-2421. PubMed ID: 30097694
[TBL] [Abstract][Full Text] [Related]
35. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
[TBL] [Abstract][Full Text] [Related]
36. Hyperthermia-induced upregulation of vascular endothelial growth factor in retinal pigment epithelial cells is regulated by mitogen-activated protein kinases.
Faby H; Hillenkamp J; Roider J; Klettner A
Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1737-45. PubMed ID: 25047875
[TBL] [Abstract][Full Text] [Related]
37. Signalling pathways activated by glucagon-like peptide-1 (7-36) amide in the rat heart and their role in protection against ischaemia.
Huisamen B; Genade S; Lochner A
Cardiovasc J Afr; 2008; 19(2):77-83. PubMed ID: 18516352
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells.
Koehler JA; Kain T; Drucker DJ
Endocrinology; 2011 Sep; 152(9):3362-72. PubMed ID: 21771884
[TBL] [Abstract][Full Text] [Related]
39. Protection of exendin-4 analogue in early experimental diabetic retinopathy.
Zhang Y; Wang Q; Zhang J; Lei X; Xu GT; Ye W
Graefes Arch Clin Exp Ophthalmol; 2009 May; 247(5):699-706. PubMed ID: 19084986
[TBL] [Abstract][Full Text] [Related]
40. Induction of differentiation by pyruvate and DMEM in the human retinal pigment epithelium cell line ARPE-19.
Ahmado A; Carr AJ; Vugler AA; Semo M; Gias C; Lawrence JM; Chen LL; Chen FK; Turowski P; da Cruz L; Coffey PJ
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7148-59. PubMed ID: 21743014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
